Cancer Research UK
Clinical Trials Unit Glasgow
 
 
 

Study Title: Cancer And Venous Access (CAVA)

Study Description: To determine which venous access device - subcutaneously tunnelled central catheters (Hickman type device), peripherally inserted central catheters (PICC) or implantable chest wall ports (Port), offers the best outcome from safety, clinical effectiveness and cost effectiveness perspectives.

Study Design: A randomised controlled trial incorporating pre and post trial qualitative research

Trial Status: Open

Chief Investigator: Professor Jon Moss

Sponsor: NHS Greater Glasgow and Clyde

Date Opened: 08 November 2013

Planned Closure Date: 30 November 2017

Target Recruitment: 1400

Open to New Sites: Yes

Contact Details: Clinical Trial Unit (CTU), Glasgow
Eileen Soulis/Susan Dillon
E-mail: Eileen.Soulis@glasgow.ac.uk/susan.dillon@glasgow.ac.uk


Click here to download the Initiation Slides

Click here to download the Protocol

For advice on reporting any unexpected events for the device to the MHRA please contact:

The Pharmacovigilance Team email: mvls-ctu-pv@glasgow.ac.uk or
Telephone: 0141 211 0352/0203/3567/3968 or 0141 232 2068

Version of NCI Common Terminology Criteria for Adverse Events (CTCAE) being used for the study: 4.2

Click here to download the CTCAE